Key Takeaways
- Sharp profit rebound, but quality is mixed: PAT jumped from ₹21 cr to ₹93 cr QoQ, driven by a 30% fertilizer volume surge and a tactical product-mix shift at Sikka, yet DAP sales alone destroyed ₹42 cr of bottom-line earnings.
- The DAP dilemma is a deliberate drag: Management is running DAP at a negative contribution because the government pressures it to supply farmers and a ₹3,500/MT subsidy hike is expected; until that notification arrives, DAP remains a breakeven-at-best proposition.
- Industrial chemicals are bleeding, with a fix in sight: The IP segment posted a ₹4 cr loss as cheap Chinese imports crushed caprolactam and melamine prices; the new HX Crystal plant and imported-Anone trials are the counter, with results promised in one to two quarters.
- Capex cycle is fully loaded: Three projects (HX Crystal, urea revamping, sulphuric acid) are racing toward year-end commissioning, promising ₹130 cr+ in incremental revenue with better margins, but delays are already acknowledged.
- What to watch next quarter: Whether the DAP subsidy notification actually lands, whether the IP segment’s cost-cutting moves show up in the P&L, and whether the urea revamp stays on its year-end schedule.
Fertilizer Operations: Volume Over Margin
- Volume engine firing: Fertilizer sales volume grew 30% YoY, with APS and NPK running at capacity at Sikka because raw material availability, economics and demand all aligned. The Kharif season accelerated on favourable rainfall, and management expects robust demand to persist.
- Margin pressure is structural for now: The government cut the fertilizer subsidy outlay ~13% in the budget, and P&K subsidy rates were significantly reduced in October 2023. Raw material prices have not fallen in step: phosphoric acid held at $850/MT, while benzene and natural gas prices rose both YoY and QoQ. Management sees no margin relief unless subsidy rates are revised.
- DAP: a ₹42 cr deliberate loss: DAP production was cut back because its economics are worse (higher phosphoric acid import dependency), but not stopped. Management is accumulating DAP inventory for the Rabi season, betting on a ₹3,500/MT NBS subsidy increase that would lift DAP to breakeven. The government notification is still awaited.
- Urea: safe but suboptimal: Natural gas prices are fully passed through, so urea margins are stable but thin. Higher energy consumption at GSFC attracts a penalty, though even after that penalty, the company’s energy consumption stays below the government’s post-penalty threshold, generating some FICC savings. No provision has been made for the penalty amount.
- Ammonium sulphate discount softened: The ₹2,000/MT discount flagged earlier has eased somewhat because the company pushed for an MRP change based on cost of production, though some sales volume was sacrificed. Q1 is the lean season for this product.
Management: "GSFC like company will never see only the profit motive, we produce and make available the required fertilizers to the farmers."
Industrial Products: Loss-Making and Under Repair
- IP segment in the red: The segment reported a ₹4 cr loss, dragged down by a capro-benzene spread that collapsed from $730 to $582/MT YoY. Domestic prices stayed subdued because of dumping of cheap Chinese caprolactam, melamine and basic nylon-6.
- Caprolactam breakeven far away: Variable-cost breakeven for the capro-benzene spread sits around $700–725/MT, well above the current $582. Fixed costs add further pressure, with management only confirming they are "higher than $100" per ton.
- Nylon-6 cost arbitrage: The company is importing cheaper nylon-6 chips from China and blending them with its own chips in compounding lines to reduce costs and improve margins.
- HX Crystal: the margin fix, delayed: A new plant will produce HX Crystal as forward integration of the caprolactam chain, diverting the old 20,000 MT caprolactam capacity. It is expected to generate ₹100 cr in revenue with good margins, but commissioning has slipped a few months and will now happen by year-end, with full-year impact only in FY26.
- Imported Anone trial done: The company has completed a trial for importing cheaper Anone instead of producing higher-cost Anone from benzene, another cost-cutting lever for the IP segment. Results from these steps are expected in the next one to two quarters.
Management: "We are taking such an innovative step to cut down the cost and make the IP segment profitable."
Capex & Project Pipeline
- Three projects racing to year-end: The urea revamp (₹450 cr), HX Crystal plant, and a sulphuric acid plant are all targeted for commissioning by the end of this financial year. Delays of a few months have already been flagged on the urea and HX Crystal projects.
- Urea revamp economics: The project will cut energy consumption by 0.6 Gcal and raise capacity from 800 to 1,123 MT per day, generating around ₹30 cr in incremental benefit. Per-ton margin improvement was not disclosed.
- Solar and sulphuric acid: A solar power plant at Charanka will improve efficiency and reduce costs. The sulphuric acid plant is subject to location finalization at Fertilizernagar.
- Phosphoric acid backward integration is years away: A project to reduce import dependency for phosphoric acid at Sikka is not immediate; management pegged it at a two-to-three-year horizon.
Raw Material & Subsidy Dynamics
- Phosphoric acid stays expensive: Prices held steady at $850/MT, and with DAP prices crossing $600, management does not expect phosphoric acid to get cheaper. This keeps DAP economics negative until the subsidy rate moves.
- Natural gas stable, impact contained: Gas prices were stable at ₹45 per SM³ with no major deviation foreseen. For urea, gas costs are fully passed through. The small amount of ammonia used in melamine and caprolactam production means gas price moves have negligible total profitability impact.
- Subsidy cash flow is healthy: Despite the 13% budget cut, the government has been prompt in releasing subsidy; payments for both P&K fertilizers and urea were received up to the first week of July.
- Market is shifting toward NPK: Sales of APS were the highest because Sikka could produce APS and NPK at capacity, and farmer demand is diverting toward NPK fertilizers. This product-mix shift is a structural tailwind for volume.
Margins & Segment Profitability
- Overall fertilizer basket margin: Management disclosed an average margin of ₹2,000–2,500/MT across the fertilizer portfolio but declined to break it out by subsegment (ammonium sulphate/APS, NPK/DAP, urea). DAP is a negative contributor within that average, and urea margins are thinner due to the energy penalty.
- DAP’s quantified damage: DAP sales caused a ₹42 cr dent in bottom-line earnings for the quarter. Management continues production despite this, citing government pressure and the philosophy of ensuring fertilizer availability.
- IP segment path to breakeven: With the capro-benzene spread at $582 against a $700–725 variable-cost breakeven, the segment needs both the cost-cutting measures to work and some recovery in international chemical prices. Management is hopeful for better results in Q2 and Q3.
- No margin tailwind from raw materials: Management sees fertilizer margins as more or less stable going forward, with no changes expected in raw material prices unless a subsidy revision happens. Volume and product mix are the only levers left.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| DAP subsidy increase | NBS rate to rise by ₹3,500/MT, lifting DAP to breakeven | Awaiting government notification |
| HX Crystal plant commissioning | Capitalized this FY; ₹100 cr revenue with good margins | By end of FY25 (full impact in FY26) |
| Urea II revamp commissioning | ₹450 cr capex; 0.6 Gcal energy saving; ₹30 cr benefit | By end of FY25 |
| IP segment improvement | Cost-cutting steps (HX Crystal, imported Anone) to show results | Next 1–2 quarters |
| Sulphuric acid plant | Subject to location finalization at Fertilizernagar | By end of FY25 |
| Phosphoric acid backward integration | Reduce import dependency at Sikka | 2–3 years |
Key Metrics
| Metric | Q1 FY25 |
|---|---|
| Revenue | ₹2,144 cr, second highest Q1 sales in 15 years |
| PBT | ₹118 cr, up from ₹23 cr in Q4 FY24 |
| PAT | ₹93 cr, up from ₹21 cr in Q4 FY24 |
| Fertilizer sales value growth | 7% YoY |
| Fertilizer sales volume growth | 30% YoY |
| Fertilizer sales volume | 4.46 lakh metric tons |
| Average fertilizer margin | ₹2,000–₹2,500 per metric ton; DAP contribution negative, urea margins lower |
| DAP bottom-line impact | ₹42 cr negative dent in the quarter |
| Industrial products segment result | ₹4 cr loss |
| Capro-benzene spread | $582 per metric ton, down from $730 per metric ton YoY; improved to $638 in July |
| Natural gas cost | ₹45 per SM³, up 6% YoY |
| Phosphoric acid price | $850 per metric ton, steady |
| Benzene price increase | 13% YoY |
| Capex to be capitalized in FY25 | ₹1,000 cr across four plants (HX Crystal, sulphuric acid, urea revamping, solar power) |
| Urea plant capacity post-revamp | 1,123 metric tons per day, up from 800; additional 323 metric tons |